Daily Health Headlines

Paid Sick Leave Can Be Crucial When Cancer Strikes

👤by Robert Preidt 0 comments 🕔Thursday, December 24th, 2015

WEDNESDAY, Dec. 23, 2015 (HealthDay News) -- Paid sick leave for cancer patients eases their financial struggles and helps them keep their jobs, a new study shows.

"Paid sick leave allows patients to take the time they need for cancer treatment but still keep getting a paycheck," study author Dr. Christine Veenstra, a clinical lecturer in internal medicine at the University of Michigan Medical School, said in a university news release.

Veenstra and colleagues surveyed more than 1,300 colon cancer patients and found that those without paid sick leave were more likely to have financial problems. Many said they had to borrow money, had trouble paying credit card bills, and had less money for food, clothing or recreation.

Only 55 percent of those employed at the time of their diagnosis still had their jobs when they finished treatment, but those with paid sick leave were nearly twice as likely to keep their jobs, the study found.

Fifty-nine percent of those with paid sick leave kept their jobs, compared with 33 percent of those without paid sick leave, according to the study published Dec. 22 in the Journal of the American Medical Association.

"Financial burden happens in a lot of different ways," Veenstra said in the news release.

"There are costs we can measure, like how much patients pay for prescriptions or doctor visits," she said. "Then there are unmeasured costs of cancer care: Did the patient take unpaid time off from work and lose paychecks? Or worse, were they unable to return to work after cancer treatment?"

About 40 percent of Americans do not have paid sick leave, which is not mandated by the U.S. government, the study authors pointed out.

"Paid sick leave can really support working Americans who have cancer or other issues as they go through their treatment," Veenstra said.

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: University of Michigan, news release, Dec. 22, 2015

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!